In vivo animal studies with sugammadex

Anaesthesia

Volumn 64, Issue SUPPL. 1, 2009, Pages 38-44

  Booij, L H D J ^a   Van Egmond, J ^a   Driessen, J J ^a   De Boer, H D ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; ATROPINE; BENZYLISOQUINOLINE DERIVATIVE; CHOLINESTERASE INHIBITOR; CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; CYCLOPHANE; EDROPHONIUM; GALLAMINE; GLYCOPYRRONIUM BROMIDE; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ORG 25288; ORG 26142; PANCURONIUM; PYRIDOSTIGMINE; ROCURONIUM; SUGAMMADEX; UNCLASSIFIED DRUG; VECURONIUM;

ACID BASE BALANCE; AIRWAY PRESSURE; BLOOD PRESSURE; BLURRED VISION; BRADYCARDIA; BRONCHOSPASM; CONTINUOUS INFUSION; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG URINE LEVEL; ENCAPSULATION; EXPERIMENTAL GUINEA PIG; HEART RATE; HUMAN; HYPERSALIVATION; IN VIVO STUDY; NAUSEA AND VOMITING; NEUROMUSCULAR BLOCKING; NONHUMAN; REFLUX ESOPHAGITIS; RETCHING; REVIEW; SIDE EFFECT; TACHYCARDIA; WHEEZING; XEROSTOMIA;

ANESTHESIA RECOVERY PERIOD; ANIMALS; GAMMA-CYCLODEXTRINS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 61849091310     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05869.x     Document Type: Review

References (36)

1. Läwen A. Über die Verbindung Lokalanästhesie mit der Narkose, über hohe Extraduraal Anästhesie und peridurale Injektionen anästhesierende Lösungen bei tabetische Magenkriesen. Beitrage der Klinische Chiruirgie 1912; 80: 168-9.
2. Wilkinson DJ. Dr F.P. de Caux-the first user of curare for anesthesia in England. Anaesthesia 1991; 46: 49-51.
3. Griffith HR, Johnson GE. The use of curare in general anesthesia. Anesthesiology 1942; 3: 418-20.
4. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery. Annals of Surgery 1954; 140: 2-34.
5. Abajian J Jr, Arrowood JG, Barrett RH, et al. Critique of study of the deaths associated with anaesthesia and surgery. Annals of Surgery 1955; 142: 138-41.
6. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective randomized, and blinded study of postoperative pulmonary complications after atracurium, vecuronium, and pancuronium. Acta Anaesthesiologica Scandinavica 1997; 41: 1095-103.
7. Murphy GHS, Szokol JW, Franklin M, et al. Postanesthetic care unit recovery times and neuromuscular blocking drugs: A prospective study of orthopedic surgical patients randomized to receive pancuronium ore rocuronium. Anesthesia and Analgesia 2004; 98: 193-200.
8. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62: 806-9.
9. Viby-Mogensen J. Postoperative residual curarisation and evidence-based anaesthesia. British Journal of Anaesthesia 2000; 84: 301-3.
10. Muir AW, Sleigh T, Marshall RJ, et al. Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations. European Journal of Anaesthesiology 1998; 15: 467-79.
11. Boros EE, Bigham EC, Boswell GE, et al. Bis- and mixed- tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting non-depolarizing neuromuscular blockers. Journal of Medicinal Chemistry 1999; 42: 206-9.
12. Booij LHDJ, van der Broek LAGM, Caulfield W, et al. Non-depolarizing neuromuscular blocking activity of bisquaternary amino di- and tripeptide derivatives. Journal of Medicinal Chemistry 2000; 43: 4822-33.
13. Gyermek L, Lee C, Cho Y-M, Nguyen N. Quaternary derivatives of gratanol diesters: potent, ultrashort acting non-depolarizing neuromuscular relaxants. Life Sciences 2006; 79: 559-69.
14. Vizi ES, Tuba Z, Mahó S, et al. A new short-acting nondepolarizing muscle relaxant (SZ1677) without cardiovascular side-effects. Acta Anaesthesiologica Scandinavica 2003; 47: 291-300.
15. Kim KS, Lew SH, Cho HY, Cheong MA. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesthesia and Analgesia 2002; 95: 1656-60.
16. Murphy GS, Szokol JW, Marymont JH, et al. Residual paralysis at the time of tracheal extubation. Anesthesia and Analgesia 2005; 100: 1840-5.
17. Grove SJA, Kaur J, Muir AW, et al. Oxyaniliniums as acetylcholinesterase inhibitors for the reversal of neuromuscular block. Biorganic and Medicinal Chemistry Letters 2002; 12: 193-6.
18. Clark JK, Cowley P, Muir AW, et al. Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block. Bioorganic and Medicinal Chemistry Letters 2002; 12: 2565-8.
19. Palin R, Clark JK, Cowley P, et al. Novel Piperidinium and Pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular block. Bioorganic and Medicinal Chemistry Letters 2002; 12: 2569-72.
20. Linssen GH. Curariform Drugs. The Action of the Different Types and Their Combinations on the Neuromuscular Transmission. PhD thesis: Nijmegen 1961.
21. Cameron KS, Fielding L, Mason R, et al. Anionic cyclophanes as potential reversal agents of muscle relaxants by chemical chelation. Bioorganic and Medicinal Chemistry Letters 2002; 12: 753-5.
22. Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. Journal of Pharmaceutical Sciences 1997; 86: 147-62.
23. Kristinsson JK, Fridriksdóttir H, Rhórisdottir S, et al. Dexamethason-Cyclodextrin-polymer co-complex in aqueous eye drops. Investigative in Opthalmology and Visual Sciences 1996; 37: 1199-203.
24. Bom A, Epemolu O, Hope F, Rutherford S, Thomson K. Selective relaxant binding agents for reversal of neuromuscular blockade. Current Opinion in Pharmacology 2006; 7: 298-302.
25. Adam JM, Bennett DJ, Bom A, Vlark JK, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. Journal of Medicinal Chemistry 2002; 45: 1806-16.
26. Tarver GJ, Grove SJA, Buchanan K, et al. 2-O-substituted cyclodextrines as reversal agents for the neuromuscular blocker Rocuronium bromide. Bioorganic and Medicinal Chemistry Letters 2002; 10: 1819-27.
27. Bom A, Bradley M, Cameron K, et al. M-Q. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angewandte Chemie International Edition 2002; 41: 265-70.
28. De Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular Block in anaesthetized Rhesus monkeys. British Journal of Anaesthesia 2006; 96: 201-6.
29. Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99: 632-7.
30. De Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Reversal of profound rocuronium neuromuscular blockade by Sugammadex in anaesthetized Rhesus monkeys. Anesthesiology 2006; 104: 718-23.
31. Mason R, Bom A. Org 25969 causes selective reversal of neuromuscular block induced by steroidal NMB's in anaesthetized guinea pigs. European Journal of Anaesthesiology 2001; 18: A100.
32. De Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. British Journal of Anaesthesia 2006; 96: 473-9.
33. Epemolu O, Mayer I, Hope F, Scullion P, Desmond P. Liquid chromatography/mass spectrometric bioanalysis of a modified-cyclodextrin (Org 25969) and Rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the plasma pharmacokinetics of Org 25969. Rapid Communications in Mass Spectrometry 2002; 16: 1946-52.
34. Bom A, van Egmond J, Hope F, van de Pol F. Rapid reversal of rocuronium-induced neuromuscular block by Org 25969 is independent of renal perfusion. Anesthesiology 2003; 99: A1158.
35. De Boer HD, van Egmond J, van de Pol F, et al. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation. British Journal of Anaesthesia 2006; 97: 681-6.
36. Bom AH, Mason R, McIndewar I. Org.25969 causes rapid reversal of rocuronium-induced neuromuscular block, independent of Acid-base status. Anesthesiology 2002; 96: A1009.